Posted 24 November 2024
Jacinta Frawley, a psychotherapist from Sutherland in Sydney, had a stage three ovarian cancer diagnosis that was unresponsive to treatment – until a new treatment handed her a new lease on life.
Click here to read the full article
Read more online at the Australian (Subscription required)
Posted February 15, 2024
Australia’s peak body for private cancer specialists will host a workshop for all medical oncologists and
cancer nurses to gain a practical immersion into how genomic testing can better refine diagnoses, help
predict cancer behaviour and create more effective treatment plans for their patients.
Posted 15 February 2024
Some oncologists are still battling to get their hands on genetic testing information to diagnose and treat cancer patients – and an upcoming pharma-supported workshop hopes to fix that.
Click here to read full article.
15 February 2024
PCPA invites medical oncologists and cancer nurses to immerse in the game-changing world of precision medicine
Melbourne. Due to high demand, Australia’s peak body for private cancer specialists will host a unique workshop for all medical oncologists and cancer nurses, to gain a practical immersion into how genomic testing can better refine diagnoses, help predict cancer behaviour and create more effective treatment plans for their patients.
Board member of the Private Cancer Physicians of Australia (PCPA) and workshop Master of Ceremonies, Dr Cameron McLaren, says genomic testing or precision medicine, is a powerful tool that remarkably unlocks the secrets of a patient’s cancer at the genetic level.
“Genomic testing, once a futuristic view of how cancer may be treated, is now transforming cancer care by offering personalised insights for both the patient and those who care for them,” Dr McLaren says. “As importantly as finding new treatments that can help our patients, genomic testing also allows us to choose which treatments will not help, so we can avoid subjecting our patients to toxicities of ineffective treatments.”
Health Industry Hub 1 February 2024
Pharma News: The Senate Community Affairs References Committee, chaired by Green’s Senator Janet Rice, held a public hearing in Sydney yesterday, spearheading an Opposition-led inquiry into equitable access to diagnosis and treatment for individuals with rare and less common cancers.
Addressing the committee, Associate Professor Christopher Steer, President of Private Cancer Physicians of Australia, emphasised “We need to end the cancer lottery where a patient with a particular diagnosis can get support for their treatment whereas another is denied … because their cancer is of the wrong type.”